Harness Therapeutics
Harness Therapeutics is developing therapies for neurodegenerative diseases using RNA translation methodologies. They aim to upregulate targets that may provide treatments for conditions such as Huntington's Disease, ALS, and Alzheimer's.
- RNA translation platform
- mRNA-targeted oligonucleotide methodologies
- Disease-modifying therapeutics for neurodegenerative diseases
Locations
Digital Popularity
Social Media
LinkedIn1,769 Followers
Competitors
Talisman develops disease-modifying therapeutics for Alzheimer's and other neurodegenerative diseases.
Exonate is a biotechnology company dedicated to improving treatment options for patients suffering from retinal vascular diseases.
Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.
Company Details
Harness Therapeutics is operated by Harness Therapeutics Limited and is a Active company incorporated on 22 August 2018 with the registered office located in Cambridge, Cambridgeshire. Harness Therapeutics Limited was registered 7 years ago.
Status
Active
Size
Micro
Directors
10
Age
7 years old
Employees
24
Turnover
Unreported
Total Assets
£8.59M
Cash in Bank
£2.76M
Total Liabilities
-£11.62M
Teams
20
11
9
3
Chief Executive Officer • Joined Sep 2023
Executive Assistant, Office Manager & HR Lead • Joined Jun 2024
Principal Scientist • Joined Dec 2023
Principal Scientist • Joined Jan 2025
Chief Business Officer • Joined Oct 2021
Chief Scientific Officer • Joined Sep 2023
Chairman Of The Board Of Directors • Joined Aug 2020
Principal Scientist In Bioinformatics • Joined Sep 2023
Principal Scientist • RNA Biology • Joined Jan 2025
Operations Manager • Joined Jul 2023
Principal Scientist • Joined Dec 2023
Principal Scientist • Joined Jan 2025
Chief Scientific Officer • Joined Sep 2023
Senior Scientist • Joined May 2022
Bioinformatician • Joined Feb 2025
Senior Scientist • Joined Apr 2022
Research Scientist • Joined May 2024
Scientific Researcher • Joined May 2024
Research Scientist • Joined Sep 2022
Senior Scientist • Joined Jan 2022
Chief Executive Officer • Joined Sep 2023
Executive Assistant, Office Manager & HR Lead • Joined Jun 2024
Principal Scientist • Joined Dec 2023
Principal Scientist • Joined Jan 2025
Chief Business Officer • Joined Oct 2021
Chief Scientific Officer • Joined Sep 2023
Chairman Of The Board Of Directors • Joined Aug 2020
Operations Manager • Joined Jul 2023
VP Programme Management & Operations • Joined Jun 2021
Principal Scientist In Bioinformatics • Joined Sep 2023
Principal Scientist • RNA Biology • Joined Jan 2025
Research Director: Cell And Molecular Biology • Joined Sep 2023
View 20 members